Altria Group, Inc. filings document formal disclosures for a U.S. tobacco and nicotine-products operating company. Form 8-K reports cover quarterly and annual results, consolidated financial statements, internal control reporting, material governance changes and completed debt issuances. The filings identify registered securities including MO common stock and exchange-listed notes, and describe senior unsecured notes and guarantees by Philip Morris USA.
Proxy materials cover annual meeting voting matters, director elections, board practices, executive compensation and pay-versus-performance disclosures. The record also includes capital-structure and financial-reporting disclosures tied to Altria's operating subsidiaries, shareholder returns, tobacco and health litigation items, FDA-regulated smoke-free products and other matters affecting its regulated consumer-products business.
Altria Group reported that Vice President and Controller Katie F. Patterson acquired 1,432 shares of common stock on February 25, 2026 through a grant or award at no cash cost, under the company’s equity compensation plans. After this award, she directly holds 18,357 shares, including 12,875 restricted stock units, and there are 266 additional shares held indirectly by her spouse.
McCarter Robert A. III reported acquisition or exercise transactions in this Form 4 filing.
ALTRIA GROUP, INC. executive Robert A. McCarter III, EVP & General Counsel, received an equity award in the form of 22,448 shares of common stock, described as Restricted Stock Units granted under the company’s equity compensation plans. Following this grant, his total reported direct holdings increased to 122,362 common shares, which the disclosure notes includes 97,180 Restricted Stock Units. This filing reflects a non-cash compensation award rather than an open-market stock purchase.
Altria Group executive Jody L. Begley reported an equity award that increases his holdings in the company. On February 25, 2026, he acquired 22,448 shares of Altria common stock as a grant or award, at a stated price of $0.00 per share, under the company’s equity compensation plans.
After this grant, Begley directly owns 313,227 common shares, which the filing notes includes 129,631 restricted stock units. He also indirectly holds 50,779 shares through the Altria Deferred Profit-Sharing Plan. The filing reflects compensation-related share accumulation rather than an open-market purchase or sale.
Altria Group SVP Charles N. Whitaker reported an equity award of 13,534 shares of common stock on February 25, 2026, recorded as a grant or award acquisition at no cash cost. The award consists of Restricted Stock Units granted under Altria’s equity compensation plans.
After this transaction, Whitaker directly holds 207,998 shares of Altria common stock, which total includes 75,107 Restricted Stock Units, and indirectly holds 1,017 shares through the Altria Deferred Profit-Sharing Plan.
Altria Group senior vice president Heather A. Newman reported an equity award of 11,973 shares of common stock on February 25, 2026, received as a grant or award under the company’s equity compensation plans at no purchase price. After this acquisition, her directly held position increased to 158,391 shares, which the footnotes state includes 87,479 restricted stock units. She also reports 5,499 shares held indirectly through the Altria Deferred Profit-Sharing Plan.
Altria Group EVP & CFO Salvatore Mancuso reported an equity award of 25,376 shares of common stock on February 25, 2026, recorded as a grant or award acquisition at $0.0000 per share. The filing notes these are Restricted Stock Units granted under Altria’s equity compensation plans, bringing his directly held total to 280,494 shares, including 108,913 Restricted Stock Units. He also reports 5,751 shares held indirectly through the Altria Deferred Profit-Sharing Plan.
Altria Group, Inc. files its annual report describing a primarily U.S.-focused tobacco and nicotine business built around Marlboro cigarettes, Black & Mild cigars, Copenhagen and Skoal MST, on! oral pouches and NJOY e‑vapor products. Reportable segments are smokeable, oral tobacco and e‑vapor, with joint-venture Horizon targeting heated tobacco sticks.
The filing highlights declining cigarette and MST volumes, growth in cigars and heavy competitive pressure from innovative and illicit nicotine products, especially flavored disposable e‑vapor. Altria details ITC orders banning NJOY ACE imports and sales, related 2025 e‑vapor goodwill and intangible impairments, and the multi‑phase Optimize & Accelerate cost and modernization program.
Extensive risk factors cover regulation (including FDA reviews, flavor and nicotine limits), litigation exposure, taxation, supply-chain and human-capital challenges, cybersecurity, climate and ESG expectations, plus equity stakes in ABI and Cronos that can face currency swings, regulatory issues and potential impairments.
Altria Group director George Munoz reported an exercise of 2,078 phantom stock units that are settled in cash and track Altria’s common stock value 1-for-1. The exercise price reference was $67.0875, based on the average high and low price of Altria common stock on February 13, 2026.
After this derivative exercise under the Deferred Fee Plan for Non-Employee Directors, Munoz held 12,471 phantom stock unit equivalents and 123,030 shares of Altria common stock directly, including 7,714 deferred shares in the Stock Compensation Plan for Non-Employee Directors.
Altria Group CEO William F. Gifford Jr. reported a transfer of 15,700 shares of common stock of Altria Group, Inc. on February 4, 2026 at a reported price of $0 per share, coded as transaction type “G.”
After this transaction, he directly beneficially owned 673,427 common shares, which the filing notes includes 243,462 Restricted Stock Units. He also indirectly held 1,747 common shares through the Altria Deferred Profit-Sharing Plan.
Altria Group, Inc. filed a current report to make its full set of audited financial statements for recent years available. The filing includes consolidated balance sheets as of December 31, 2025 and 2024, as well as consolidated statements of earnings, comprehensive earnings, stockholders’ equity (deficit) and cash flows for each of the three years ended December 31, 2025.
The report also contains the independent registered public accounting firm’s opinion on these financial statements and on the effectiveness of Altria’s internal control over financial reporting, along with management’s own report on internal control. These same materials will also be included in Altria’s upcoming Annual Report on Form 10-K for the year ended December 31, 2025.